HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): James E. Thomas Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cole, F. H. Articles by Halford, H. H. Search for Related Content PubMed PubMed Citation Articles by Cole, F. H., Jr Articles by Halford, H. H., III

Ann Thorac Surg 1994;57:838-840
© 1994 The Society of Thoracic Surgeons

---

Articles

Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: Is it worthwhile?

Departments of Radiology and Surgery, Methodist Hospitals of Memphis, and Department of Surgery, University of Tennessee Center for the Health Sciences, Memphis, Tennessee, USA

^_* Address reprint requests to Dr Cole, 1325 Eastmoreland, Ste 310, Memphis, TN 38104.

The issue of screening for cerebral metastatic disease in the preoperative bronchogenic carcinoma patient remains unsettled and changes with advancing technology. A prospective nonrandomized study was designed to compare contrast magnetic resonance imaging (MRI) with computed tomography (CT) after several clinical situations suggested improved sensitivity for the former study. Patients with clinically operable disease and normal neurologic examinations were referred for both enhanced cerebral CT and MRI studies. Forty-two patients were entered and completed the enhanced CT scan; only 30 tolerated the MRI. The demographic data and histology of the patients appeared fairly typical for a series of operative candidates. No unsuspected metastatic lesion was found in this selected and low-risk group. We conclude that neither MRI nor enhanced CT scan is indicated in the asymptomatic bronchogenic carcinoma patient due to expense and lack of positive findings. Magnetic resonance imaging demonstrated more subtle benign pathology, but this study did not allow comparison of the two techniques in detection of metastatic disease.

This article has been cited by other articles:

				E. Lim, D. Baldwin, M. Beckles, J. Duffy, J. Entwisle, C. Faivre-Finn, K. Kerr, A. Macfie, J. McGuigan, S. Padley, et al. Guidelines on the radical management of patients with lung cancer Thorax, October 1, 2010; 65(Suppl_3): iii1 - iii27. [Abstract] [Full Text] [PDF]

				G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF]

				E. M. Toloza, L. Harpole, and D. C. McCrory Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence Chest, January 1, 2003; 123(2009): 137S - 146S. [Abstract] [Full Text] [PDF]

				J. Deslauriers and J. Gregoire Clinical and Surgical Staging of Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(2009): 96S - 103S. [Abstract] [Full Text] [PDF]

				K. Yokoi, N. Kamiya, H. Matsuguma, S. Machida, T. Hirose, K. Mori, and K. Tominaga Detection of Brain Metastasis in Potentially Operable Non-small Cell Lung Cancer: A Comparison of CT and MRI Chest, March 1, 1999; 115(3): 714 - 719. [Abstract] [Full Text] [PDF]